Featured Article
FDA Requests Immediate Removal of Ranitidine (Zantac) Drugs Over Cancer Risks
FDA Requests Immediate Removal of Ranitidine (Zantac) Drugs Over Cancer Risks

On April 1, 2020, the U.S. Food & Drug Administration (FDA) announced that it is requesting manufacturers to withdraw all over-the-counter and prescription drugs containing ranitidine from the market immediately. Ranitidine, known by the brand name Zantac, is widely used to ...

Read More